Related references
Note: Only part of the references are listed.Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
A. J. Varewijck et al.
DIABETOLOGIA (2012)
Direct Recruitment of Insulin Receptor and ERK Signaling Cascade to Insulin-Inducible Gene Loci
Joel D. Nelson et al.
DIABETES (2011)
Insulin X10 revisited: a super-mitogenic insulin analogue
B. F. Hansen et al.
DIABETOLOGIA (2011)
Growth effects of insulin and insulin analogues
Juergen Sandow
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
Insulin and its analogs: actions via insulin and IGF receptors
R. Vigneri et al.
ACTA DIABETOLOGICA (2010)
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
L. Sciacca et al.
DIABETOLOGIA (2010)
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir
A. J. Varewijck et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Insulin and Insulin-like Growth Factor-1 Receptors Act as Ligand-specific Amplitude Modulators of a Common Pathway Regulating Gene Transcription
Jeremie Boucher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Mark R. Sommerfeld et al.
PLOS ONE (2010)
Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice
Jutta M. Nagel et al.
Hormones & Cancer (2010)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Beyond the era of NPH insulin - Long-acting insulin analogs: Chemistry, comparative pharmacology, and clinical application
D. R. Owens et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
Insulin analogues with increased mitogenic potency - Are they safe?
B. F. Hansen
HORMONE AND METABOLIC RESEARCH (2008)
Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I
E. Liefvendahl et al.
HORMONE AND METABOLIC RESEARCH (2008)
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays
Michael P. Brugts et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Proliferative effects of insulin analogues on mammary epithelial cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts
K. Eckardt et al.
DIABETOLOGIA (2007)
Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells
K. Staiger et al.
HORMONE AND METABOLIC RESEARCH (2007)
Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
H Yki-Järvinen et al.
DIABETOLOGIA (2006)
Insulin glulisine - A comprehensive preclinical evaluation
I Stammberger et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2006)
Insulin receptor signaling characteristics in vivo
AM Hennige et al.
DIABETES (2005)
Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR
A Denley et al.
MOLECULAR ENDOCRINOLOGY (2004)
The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
S Havelund et al.
PHARMACEUTICAL RESEARCH (2004)
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
T Heise et al.
DIABETES (2004)
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
A Juul
GROWTH HORMONE & IGF RESEARCH (2003)
Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
P Vague et al.
DIABETES CARE (2003)
Biotransformation of insulin glargine after subcutaneous injection in healthy subjects
GU Kuerzel et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
G Pandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors
K Siddle et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction
J Dupont et al.
HORMONE RESEARCH (2001)
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
P Kurtzhals et al.
DIABETES (2000)
Share Paper
